Today: 20 November 2025
Subscribe
Browse Tag

price war

Hims & Hers Health Stock Skyrockets amid Weight-Loss Mania – But FDA Scrutiny Looms

HIMS Stock Today (November 18, 2025): Buyback, GLP‑1 Price War and What It Means for Hims & Hers Investors

On Tuesday, November 18, 2025, Hims & Hers Health (NYSE: HIMS) is trading in the shadow of a sharp sell‑off, a fresh $250 million share repurchase authorization, and escalating price competition in the weight‑loss drug market. Together, these forces are shaping how traders and long‑term investors are thinking about HIMS stock today. HIMS stock price snapshot for November 18, 2025 As of the latest available data, Hims & Hers shares closed on Monday, November 17 at $35.58, down 3.79% on the day. Pre‑market indications early Tuesday showed the stock changing hands around $35.00, about 1.6% lower from Monday’s close, suggesting
18 November 2025
 ·  ·  ·  ·  · 
BYD’s European EV Invasion – Boom in Sales but Stock Takes a Hit

BYD Stock Plunges 30% on Profit Slump – Is the EV Price War to Blame?

BYD Shares: Price and Recent Moves BYD’s stock has experienced a sharp correction in recent months. In early 2025 the Hong Kong-listed shares hit record highs (above HK$150 in May), but by late October they traded near HK$104 reuters.com – roughly 30% below the peak bloomberg.com. This slide erased tens of billions in market value. For example, Bloomberg reports the company lost over $45 billion of market cap as stock slid 32% from May to October bloomberg.com. Investors have blamed weaker-than-expected earnings and slowing growth in China. On Oct. 29, trading ahead of the earnings release, BYD’s Hong Kong shares rose
30 October 2025
 ·  ·  ·  · 
Go toTop